Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PHAR Pharming Group > Company Profile
PHAR Pharming Group
13.450
+0.080+0.60%
Post Mkt Price
13.4500.0000.00%
Symbol
PHAR
Company Name
Pharming Group
Establishment Date
1988
CEO
Dr. Sijmen (Simon) de Vries, M.D.
Market
NASDAQ
Employees
277
Securities Type
DR
ADS Ratio
1.0 : 10.0
Fiscal Year Ends
12-31
Address
Darwinweg 24
City
Leiden
Province
Zuid-Holland
Country
Netherlands (the)
Zip code
2332 CR
Phone
31-71-524-74-00
Profile
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
Company Overview
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
CEO: Dr. Sijmen (Simon) de Vries, M.D.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist